Analysis on the expression level of ADAM17 in lung adenocarcinoma with pleural metastasis and tuberculous pleurisy

Meijun Wang,Lian Li,Wu Huyan,Jiancheng Tu,Junyuan Zheng
DOI: https://doi.org/10.3969/j.issn.1672-4992.2017.23.010
2017-01-01
Journal of Modern Oncology
Abstract:Objective:To observe and investigate the ADAM17 expression level in lung adenocarcinoma with pleural metastasis and tuberculous pleurisy.Methods:Evaluating the pleural basic situation by HE staining and using immunohistochemisty and immunoblotting to detect the ADAM17 expression level in group A with adenocarcinoma of pleural metastasis, group B with tuberculous pleurisy and group C with healthy people.Results:The ADAM17 expression level in group A was higher than group B and group C, and the level in group C was higher than in group B.Expression of ADAM17 value in group A was 50.0%,the positive expression of group B was 16.67%, the positive expression of group C was 30.0%, the differences in the three groups were significant(P < 0.05).Conclusion:The ADAM17 expression level in lung cacer with pleural metastasis was higher than in tuberculous pleurisy, which speculated that ADAM17 and has a certain value in the differential diagnosis of lung adenocarcinoma with pleural metastasis tuberculous pleurisy.
What problem does this paper attempt to address?